LEADER 00000cam  2200745 i 4500 
001    on1048400787 
003    OCoLC 
005    20180905093156.0 
006    m     o  d f       
007    cr ||||||||||| 
008    180813s2018    mdua    ob   f000 0 eng c 
020    9780160943751|q(epub) 
020    0160943752|q(epub) 
020    9780160943768|q(mobi) 
020    0160943760|q(mobi) 
020    9780160943775|q(pdf) 
020    0160943779|q(pdf) 
035    (OCoLC)1048400787 
037    017-300-00047-4 (epub)|bGPO 
037    017-300-00048-2 (mobi)|bGPO 
037    017-300-00049-1 (pdf)|bGPO 
040    GPO|beng|erda|epn|cGPO|dKOS|dMMU|dSTJ 
042    pcc 
043    n-us--- 
049    STJJ 
050  4 RC568.O45 
060  4 WM 284 
074    0497-D-18 (online) 
086 0  HE 20.418:63 
099    WORLD|aWIDE|aWEB|aE-BOOK|aR2 
245 00 Medications for opioid use disorder :|bfor healthcare and 
       addiction professionals, policymakers, patients, and 
       families. 
264  1 [Rockville, Md.] :|bU.S. Department of Health and Human 
       Services, Substance Abuse and Mental Health Services 
       Administration, Center for Substance Abuse Treatment,
       |c2018. 
264  2 [Washington, D.C.] :|b[Distributed by the Superintendent 
       of Documents, U.S. Government Publishing Office] 
300    1 online resource (322 unnumbered pages) :|bcolor 
       illustrations. 
336    text|2rdacontent 
337    computer|2rdamedia 
338    online resource|2rdacarrier 
490 1  Treatment improvement protocol, TIP ;|v63 
490 1  HHS publication ;|vno. (SMA) 18-5063FULLDOC 
500    "Printed 2018"--Page 4 of cover. 
504    Includes bibliographical references. 
505 0  Part 1: An introduction to medications for the treatment 
       of opioid use disorder. The approach to OUD care -- 
       Overview of medications for OUD -- Duration of treatment 
       with OUD medication -- Treatment settings -- Challenges to
       expanding access to OUD medication -- Resources -- Notes -
       - Part 2: Addressing opioid use disorder in general 
       medical settings. Scope of the Problem -- Screening -- 
       Assessment -- Treatment planning or referral -- Resources 
       -- Appendix -- Notes -- Part 3: Pharmacotherapy for opioid
       use disorder. Pharmacotherapy for opioid use disorder -- 
       Overview of pharmacotherapy for opioid use disorder. 
       Methadone -- Naltrexone -- Buprenorphine -- Medical 
       management strategies for patients taking OUD medications 
       in office-based settings -- Medical management of patients
       taking OUD medications in hospital settings -- PART 4: 
       Partnering addiction treatment counselors with clients and
       healthcare professionals. Overview and context -- Quick 
       guide to medications -- Counselor-prescriber 
       communications -- Creation of a supportive counseling 
       experience -- Other common counseling concerns -- Notes --
       Part 5: Resources related to medications for opioid use 
       disorder. General Resources -- Resources for counselors 
       and peer providers -- Resources for clients and families -
       - Provider tools and sample forms -- Glossary of TIP 
       terminology -- Notes 
536    Prepared by the Knowledge Application Program (KAP) for 
       the Center for Substance Abuse Treatment, Substance Abuse 
       and Mental Health Services Administration (SAMHSA), U.S. 
       Department of Health and Human Services (HHS) under 
       contract number|b270-14-0445 
588    Description based on online resource, PDF version; title 
       from cover (SAMHSA website, viewed Aug. 13, 2018). 
650  0 Opioid abuse|xTreatment|zUnited States|vHandbooks, manuals,
       etc. 
650  0 Opioid abuse|xChemotherapy|zUnited States|vHandbooks, 
       manuals, etc. 
650  0 Opioids|xOverdose|xTreatment|zUnited States|vHandbooks, 
       manuals, etc. 
650  0 Drug addicts|xRehabilitation|zUnited States|vHandbooks, 
       manuals, etc. 
650 12 Opioid-Related Disorders|xdrug therapy. 
651  2 United States. 
650 22 Opiate Substitution Treatment|xmethods. 
650 22 Narcotic Antagonists|xtherapeutic use. 
650 22 Buprenorphine|xtherapeutic use. 
650 22 Naltrexone|xtherapeutic use. 
650 22 Methadone|xtherapeutic use. 
655  2 Handbooks. 
655  7 Handbooks and manuals.|2lcgft 
710 2  Center for Substance Abuse Treatment (U.S.),|eissuing 
       body. 
710 2  Knowledge Application Program (U.S.) 
830  0 Treatment improvement protocol (TIP) series ;|v63. 
830  0 DHHS publication ;|vno. (SMA) 18-5063FULLDOC. 
994    C0|bSTJ